Beverly Hills Private Wealth LLC Has $313,000 Stock Holdings in Relx Plc $RELX

Beverly Hills Private Wealth LLC reduced its position in shares of Relx Plc (NYSE:RELX) by 5.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,767 shares of the technology company’s stock after selling 304 shares during the period. Beverly Hills Private Wealth LLC’s holdings in Relx were worth $313,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Carnegie Investment Counsel acquired a new stake in shares of Relx during the first quarter worth $16,026,000. Ameriprise Financial Inc. boosted its position in shares of Relx by 8.3% in the first quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company’s stock valued at $154,129,000 after acquiring an additional 234,094 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Relx by 103.4% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 444,360 shares of the technology company’s stock valued at $22,400,000 after acquiring an additional 225,947 shares during the period. Northern Trust Corp boosted its position in shares of Relx by 9.2% in the first quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company’s stock valued at $120,686,000 after acquiring an additional 202,509 shares during the period. Finally, Janney Montgomery Scott LLC boosted its position in shares of Relx by 304.6% in the second quarter. Janney Montgomery Scott LLC now owns 242,649 shares of the technology company’s stock valued at $13,186,000 after acquiring an additional 182,673 shares during the period. 15.02% of the stock is owned by institutional investors and hedge funds.

Relx Trading Up 1.9%

Shares of RELX opened at $46.09 on Tuesday. Relx Plc has a 52-week low of $44.19 and a 52-week high of $56.33. The business’s fifty day moving average is $46.73 and its 200-day moving average is $50.61. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47. The firm has a market cap of $84.22 billion, a price-to-earnings ratio of 24.78, a PEG ratio of 2.97 and a beta of 0.87.

Relx Cuts Dividend

The firm also recently declared a semi-annual dividend, which was paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th were paid a $0.2634 dividend. The ex-dividend date was Friday, August 8th. This represents a dividend yield of 170.0%. Relx’s dividend payout ratio (DPR) is presently 28.49%.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Kepler Capital Markets raised shares of Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Barclays reissued an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th. Weiss Ratings restated a “buy (b)” rating on shares of Relx in a research note on Wednesday, October 8th. Morgan Stanley restated an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. Finally, Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy”.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.